Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Fate Therapeutics is a biopharmaceutical company developing off-the-shelf cellular immunotherapies using proprietary induced pluripotent stem cell (iPSC) technology. Its focus includes engineered T-cell and natural killer (NK) cell products for autoimmune diseases and solid tumors. The company leverages innovative synthetic controls, gene editing, and scalable manufacturing to create targeted, durable, and accessible cell therapies aimed at addressing unmet medical needs across cancer and autoimmune indications.
This description was generated via AI from an annual report. Updated about 1 year ago.